DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ethell, B. T.
Right arrow Articles by Burchell, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ethell, B. T.
Right arrow Articles by Burchell, B.

Vol. 30, Issue 6, 734-738, June 2002

Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9

Brian T. Ethell, Sean Ekins, Jibo Wang, and Brian Burchell

Department of Molecular and Cellular Pathology, Ninewells Hospital and Medical School, Dundee, United Kingdom (B.T.E., B.B.); and Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana (S.E., J.W.)

UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with both isoforms and then used as model substrates for the generation of Vmax and Km values. UGT1A6 showed a more restricted acceptance of phenolic substrates compared with UGT1A9. However, the affinity of UGT1A6 for these compounds exhibited higher Km values than UGT1A9, although rates of turnover were similar. Molecular surface-weighted holistic invariant molecular descriptors were generated for each substrate and used to produce the first quantitative structure activity relationship models generated for expressed human UGTs. Models relating log of the Km value to the generated descriptors correlated well with the experimental data r2 value of 0.996 for UGT1A6 and r2 value of 0.83 for UGT1A9. Cross validation by a leave-one-out method also showed good predictive capability within the subset with a q2 value of 0.98 for UGT1A6 and q2 value of 0.73 for UGT1A9. Empirically, UGT1A6 Vmax decreased as the 4-substituent increased in size, and a trend was observed when UGT1A6 Vmax was plotted against molecular volume. The larger UGT1A6 substrates were typified by low activity and lower Km values than their smaller counterparts. Extrapolating from this, it was demonstrated that phenols with large 4-substituents, which were not UGT1A6 substrates, could inhibit 4-ethylphenol glucuronidation. The Km values for UGT1A9 showed a similar relationship to UGT1A6 but with much lower Km values and greater variability in range of this value.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
Y. Zhen, K. W. Krausz, C. Chen, J. R. Idle, and F. J. Gonzalez
Metabolomic and Genetic Analysis of Biomarkers for Peroxisome Proliferator-Activated Receptor {alpha} Expression and Activation
Mol. Endocrinol., September 1, 2007; 21(9): 2136 - 2151.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. E. Kuehl, J. W. Lampe, J. D. Potter, and J. Bigler
GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos., July 1, 2005; 33(7): 1027 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Krishnaswamy, Q. Hao, L. L. von Moltke, D. J. Greenblatt, and M. H. Court
EVALUATION OF 5-HYDROXYTRYPTOPHOL AND OTHER ENDOGENOUS SEROTONIN (5-HYDROXYTRYPTAMINE) ANALOGS AS SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 1A6
Drug Metab. Dispos., August 1, 2004; 32(8): 862 - 869.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. E. Kuehl and S. E. Murphy
N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES
Drug Metab. Dispos., November 1, 2003; 31(11): 1361 - 1368.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.